Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLVN.L Regulatory News (BLVN)

  • There is currently no data for BLVN

Director/PDMR Shareholding

20 Oct 2011 16:47

RNS Number : 5742Q
BowLeven Plc
20 October 2011
 

20 October 2011

 

Bowleven plc ("Bowleven" or the "Company")

 

Directors' interests

 

The Company announces that on 19 October 2011, pursuant to a conditional placing of 77,500,000 new ordinary shares in the capital of the Company at a placing price of 103 pence each, the following dealings (direct or indirect) by directors of Bowleven took place (in accordance with a derogation granted to the Company in respect of AIM rule 21) pursuant to the conditional placing:-

 

Ronnie Hanna, Non-Executive Chairman of the Company, has agreed to subscribe for 20,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Ronnie Hanna's total beneficial shareholding in the Company will be 330,125 shares which at that time will represent approximately 0.11% of the then enlarged issued share capital of the Company.

 

Kevin Hart, Chief Executive Officer of the Company, has agreed to subscribe for 200,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Kevin Hart's total beneficial shareholding in the Company will be 2,190,000 shares which at that time will represent approximately 0.75% of the then enlarged issued share capital of the Company.

 

John Brown, Finance Director of the Company, has agreed to subscribe for 25,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, John Brown's total beneficial shareholding in the Company will be 122,675 shares which at that time will represent approximately 0.04% of the then enlarged issued share capital of the Company.

 

Ed Willett, Exploration Director of the Company has agreed to subscribe for 25,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Ed Willett's total beneficial shareholding in the Company will be 217,235 shares which at that time will represent approximately 0.07% of the then enlarged issued share capital of the Company.

 

Peter Wilson, Director and General Counsel of the Company, has agreed to subscribe for 25,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Peter Wilson's total beneficial shareholding in the Company will be 277,119 shares which at that time will represent approximately 0.09% of the then enlarged issued share capital of the Company.

 

Tim Sullivan, Non-Executive Director of the Company, has agreed to subscribe for 50,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Tim Sullivan's total beneficial shareholding in the Company will be 146,745 shares which at that time will represent approximately 0.05% of the then enlarged issued share capital of the Company.

 

The allotment of the new ordinary shares pursuant to the conditional placing is subject to, amongst other things, the required shareholder approval to be sought at the Company's General Meeting being held on Monday 7 November 2011.

 

ENQUIRIES

For further information please contact:

 

Bowleven plc

Kevin Hart, Chief Executive

00 44 131 524 5678

Kerry Crawford, Head of Investor Relations

BofA Merrill Lynch

00 44 207 628 1000

Andrew Osborne

Tony White

Brunswick Group LLP

Patrick Handley

00 44 207 404 5959

Natalia Erikssen

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSPGGQCUUPGGAU
Date   Source Headline
30th Nov 20073:59 pmRNSHolding(s) in Company
29th Nov 200710:24 amRNSHolding(s) in Company
20th Nov 20071:53 pmRNSBowleven IFRS Restatement
12th Nov 20079:45 amRNSHolding(s) in Company
12th Nov 20079:41 amRNSHolding(s) in Company
12th Nov 20077:00 amRNSPreliminary Results
8th Nov 20075:28 pmRNSTotal Voting Rights
8th Nov 20079:20 amRNSHolding(s) in Company
8th Nov 20079:17 amRNSHolding(s) in Company
2nd Nov 20076:30 pmRNSHolding(s) in Company
2nd Nov 20076:23 pmRNSHolding(s) in Company
2nd Nov 20076:18 pmRNSHolding(s) in Company
2nd Nov 20076:13 pmRNSHolding(s) in Company
2nd Nov 20076:10 pmRNSHolding(s) in Company
25th Oct 200711:32 amRNSAdditional Listing
24th Oct 20074:54 pmRNSHolding(s) in Company
24th Oct 20074:42 pmRNSHolding(s) in Company
24th Oct 20074:35 pmRNSHolding(s) in Company
8th Oct 200712:44 pmRNSHolding(s) in Company
2nd Oct 200712:46 pmRNSHolding(s) in Company
17th Sep 20072:55 pmRNSHolding(s) in Company
13th Sep 20073:09 pmRNSHolding(s) in Company
13th Sep 20073:03 pmRNSHolding(s) in Company
7th Sep 200711:14 amRNSHolding(s) in Company
31st Aug 20079:26 amRNSAdditional Listing
29th Aug 20077:00 amRNSTotal Voting Rights
16th Aug 200712:48 pmRNSWebsite Address
10th Aug 20077:00 amRNSOperational Update
30th Jul 20072:46 pmRNSAdditional Listing
19th Jul 20077:00 amRNSOperational Update
12th Jul 20075:33 pmRNSHolding(s) in Company
12th Jul 200711:20 amRNSHolding(s) in Company
9th Jul 20076:15 pmRNSDirector/PDMR Shareholding
6th Jul 20076:25 pmRNSHolding(s) in Company
3rd Jul 20077:01 amRNSOperational Update
25th Jun 200710:09 amRNSHolding(s) in Company
13th Jun 20073:12 pmRNSAdditional Listing
13th Jun 20073:10 pmRNSOperational Update
29th May 200711:01 amRNSHolding(s) in Company
29th May 200710:19 amRNSHolding(s) in Company
29th May 20079:11 amRNSHolding(s) in Company
22nd May 20074:14 pmRNSDirector/PDMR Shareholding
15th May 20072:57 pmRNSDirector/PDMR Shareholding
25th Apr 20077:00 amRNSDrilling Report
23rd Apr 200712:11 pmRNSAdditional Listing
10th Apr 20077:01 amRNSFarm-out of Epameno PSC
3rd Apr 200711:21 amRNSAdditional Listing
22nd Mar 20077:01 amRNSInterim Results
21st Mar 200711:13 amRNSHolding(s) in Company
21st Mar 20078:37 amRNSOperational Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.